Research articles
ScienceAsia 48 (2022): 734-739 |doi:
10.2306/scienceasia1513-1874.2022.111
Dexmedetomidine promotes cell proliferation and attenuates
insulin resistance in high glucose induced trophoblast cells
via inactivating the p38 MAPK pathway
Xiaofeng Song*, Zhiqiang Shao, Ping Xu
ABSTRACT: Gestational diabetes mellitus (GDM) is a disease that occurs during pregnancy. Promoting the proliferation
and migration of trophoblast cells and increasing insulin sensitivity are the strategies to improve GDM. Dexmedetomidine (DEX) is a highly selective ? 2-adrenoceptor agonist with sedative and analgesic effects and has been widely
used in clinical anesthesia. However, the exact effect of DEX on GDM is still unclear. In this study, the effects of DEX
on the progression of GDM were investigated. A high glucose (HG) cell model was constructed via treating Human
trophoblast cell line HTR-8/SVneo with 25 mmol/l glucose. The results showed that DEX promoted HTR-8/SVneo cell
proliferation of high glucose induced cells and suppressed the apoptosis. In addition, DEX promoted insulin sensitivity
in hTR-8 /SVneo cells induced by high glucose. Mechanically, DEX suppressed the p38 MAPK pathway in hTR-8/SVneo
cells, resulting in stimulation of cell proliferation and suppression of insulin resistance. In conclusion, these results
suggested that DEX promotes cell proliferation and attenuates insulin resistance in GDM.
Download PDF
86 Downloads 1097 Views
| a |
Department of Anesthesiology, Fuyang Health Hospital for Women and Children, Hangzhou, Zhejiang 311400 China |
* Corresponding author, E-mail: songxiaofeng_0220@163.com
Received 23 Feb 2022, Accepted 4 Jun 2022
|
